1.Kriengkauykiat, J, Ito, JI, Dadwal, SS. Epidemiology and treatment approaches in management of invasive fungal infections. Clinical Epidemiology 2011; 3: 175–191.
2.Kontoyiannis, DP, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clinical Infectious Diseases 2010; 50: 1091–1100.
3.Bénet, T, et al. Reduction of invasive aspergillosis incidence among immunocompromised patients after control of environmental exposure. Clinical Infectious Diseases 2007; 45: 682–686.
4.Yokoe, D, et al. Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated. Bone Marrow Transplantation 2009; 44: 495–507.
5.Eckmanns, T, Rüden, H, Gastmeier, P. The influence of high-efficiency particulate air filtration on mortality and fungal infection among highly immunosuppressed patients: a systematic review. Journal of Infectious Diseases 2006; 193: 1408–1418.
6.Humphreys, H. Positive-pressure isolation and the prevention of invasive aspergillosis. What is the evidence? Journal of Hospital Infection 2004; 56: 93–100.
7.De Pauw, B, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clinical Infectious Diseases 2008; 46: 1813–1821.
8.Falvey, DG, Streifel, AJ. Ten-year air sample analysis of Aspergillus prevalence in a university hospital. Journal of Hospital Infection 2007; 67: 35–41.
9.Nihtinen, A, et al. Invasive Aspergillus infections in allo-SCT recipients: environmental sampling, nasal and oral colonization and galactomannan testing. Bone Marrow Transplantation 2010; 45: 333–338.
10.Hahn, T, et al. Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies. Infection Control and Hospital Epidemiology 2002; 23: 525–531.
11.Curtis, L, et al. Aspergillus surveillance project at a large tertiary-care hospital. Journal of Hospital Infection 2005; 59: 188–196.
12.Alberti, C, et al. Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients. Journal of Hospital Infection 2001; 48: 198–206.
13.Hospenthal, DR, Know-Chung, KJ, Bennet, JE. Concentration of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Medical Mycology 1998; 36: 165–168.
14.Fournel, I, et al. Airborne Aspergillus contamination during hospital construction works: Efficacy of protective measures. American Journal of Infection Control 2010; 38: 189–194.
15.Leenders, ACAP, et al. Density and molecular epidemiology of Aspergillus in air and relationship to outbreaks of Aspergillus infection. Journal of Clinical Microbiology 1999; 37: 1752–1757.
16.Brenier-Pinchart, MP, et al. Influence of internal and outdoor factors on filamentous fungal flora in hematology wards. American Journal of Infection Control 2009; 37: 631–637.
17.Panackal, AA, et al. Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation. Clinical Infection Diseases 2010; 50: 1588– 1597.